Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 360.83M P/E - EPS this Y 7.80% Ern Qtrly Grth -
Income -96.71M Forward P/E -4.17 EPS next Y 2.80% 50D Avg Chg -8.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg 18.00%
Dividend N/A Price/Book 1.80 EPS next 5Y - 52W High Chg -47.00%
Recommedations 2.20 Quick Ratio 17.59 Shares Outstanding 50.23M 52W Low Chg 282.00%
Insider Own 3.47% ROA -26.73% Shares Float 29.30M Beta 1.28
Inst Own 87.64% ROE -42.23% Shares Shorted/Prior 321.31K/1.09M Price 8.71
Gross Margin - Profit Margin - Avg. Volume 234,361 Target Price 18.50
Oper. Margin - Earnings Date - Volume 104,530 Change 1.52%
About Icosavax, Inc.

Icosavax, Inc., a biopharmaceutical company, develops vaccines against infectious diseases through virus-like particle (VLP) platform technology. Its lead product candidate IVX-A12, a respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) VLP vaccine. The company also develops IVX-121, a vaccine candidate with RSV target and is under Phase 1/1b clinical trial; and IVX-241, a vaccine candidate with hMPV target. Icosavax, Inc. was incorporated in 2017 and is headquartered in Seattle, Washington. As of February 19, 2024, Icosavax, Inc. operates as a subsidiary of AstraZeneca PLC.

ICVX Chatroom

User Image Stock_Titan Posted - 22 hours ago

$ICVX Frazier Life Sciences Adds Industry Veteran and Serial Dealmaker, Adam Simpson, to Company Creation Team https://www.stocktitan.net/news/ICVX/frazier-life-sciences-adds-industry-veteran-and-serial-dealmaker-sav2daf83s7z.html

User Image NVDAMillionaire Posted - 1 month ago

$ICVX Icosavax, Inc. (NASDAQ:ICVX): A Promising Vaccine Developer Navigating the Competitive Landscape http://beyondspx.com/2024/08/05/icosavax-inc-nasdaqicvx-a-promising-vaccine-developer-navigating-the-competitive-landscape/

User Image lasercut Posted - 05/22/24

$NVAX $ICVX was bought up for $2billion . This one truly deserves $10 -15 billion valuation . Do the research

User Image Shepherd777 Posted - 4 months ago

$ICVX My wife's a pharmacist, and she's telling me to load up on this because of some new vaccine coming out 🤔. I gotta do some DD...

User Image WalnutCreekWolf Posted - 6 months ago

$ICVX 💵

User Image tradethehalt Posted - 7 months ago

$ICVX trade halt (T12) was alerted to our Members at 7:50pm EST. Halt price: $15.39 Vol: 9.32M.

User Image insiderbuyingselling Posted - 7 months ago

$ICVX new insider selling: 15000 shares. http://insiderbuyingselling.com/?t=ICVX

User Image cctranscripts Posted - 01/23/24

Icosavax, Inc.'s Chief Executive Officer just picked up 98,016 shares https://www.conferencecalltranscripts.org/summary/?id=12888913 $ICVX

User Image STCKPRO Posted - 8 months ago

$ICVX NEW ARTICLE : Icosavax ticks lower as HSR filing for AstraZeneca deal withdrawn, refiled https://stck.pro/news/ICVX/73171083/

User Image cctranscripts Posted - 8 months ago

Solicitation, recommendation statements https://www.conferencecalltranscripts.org/summary/?id=12879236 $ICVX

User Image risenhoover Posted - 8 months ago

$ICVX / Icosavax files form SC 14D9/A https://fintel.io/doc/sec-icosavax-inc-1786255-sc-14d9a-2024-january-19-19741-2741?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing

User Image cctranscripts Posted - 8 months ago

Tender offer statement by Third Party https://www.conferencecalltranscripts.org/summary/?id=12879210 $ICVX

User Image risenhoover Posted - 8 months ago

$ICVX / Icosavax files form SC 14D9/A https://fintel.io/doc/sec-icosavax-inc-1786255-sc-14d9a-2024-january-11-19733-1231?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing

User Image cctranscripts Posted - 8 months ago

Statement of acquisition of beneficial ownership by individuals https://www.conferencecalltranscripts.org/summary/?id=12856563 $ICVX

User Image ChartMill Posted - 8 months ago

$ICVX: SHAREHOLDER RIGHTS INVESTIGATION: Halper Sadeh LLC Investigates $ICVX, CVLY, PGTI, KRTX https://www.chartmill.com/stock/quote/ICVX/news?utm_source=prnews-2024-1-9-shareholder-rights-investigation-halper-sadeh-llc-investigates-icvx-cvly-pgti-krtx&utm_medium=stocktwits&utm_campaign=pressRelease

User Image MarketBeatInsiderTrades Posted - 8 months ago

Icosavax Insider Niranjan Kanesa-Thasan Sells $1,670,056.10 in $ICVX www.marketbeat.com/stocks/NASDAQ/ICVX/insider-trades/

User Image cctranscripts Posted - 8 months ago

Icosavax, Inc.'s Chief Medical Officer just cashed-in 106,373 options https://www.conferencecalltranscripts.org/summary/?id=12847635 $ICVX

User Image risenhoover Posted - 8 months ago

Insider Niranjan Kanesa-thasan reports selling 106,373 shares of $ICVX for a total cost of $1,670,460.32 https://fintel.io/n/us/icvx/kanesa-thasan-niranjan?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=insider

User Image MarketBeatInsiderTrades Posted - 8 months ago

Icosavax CEO Adam Simpson Sells $235,050.00 in $ICVX www.marketbeat.com/stocks/NASDAQ/ICVX/insider-trades/

User Image cctranscripts Posted - 8 months ago

Icosavax, Inc.'s Chief Executive Officer just cashed-in 15,000 options https://www.conferencecalltranscripts.org/summary/?id=12843747 $ICVX

User Image risenhoover Posted - 8 months ago

Insider Simpson Adam K. reports selling 15,000 shares of $ICVX for a total cost of $235,087.50 https://fintel.io/n/us/icvx/simpson-adam-k?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=insider

User Image cctranscripts Posted - 8 months ago

Report of proposed sale of securities https://www.conferencecalltranscripts.org/summary/?id=12843486 $ICVX

User Image ChartMill Posted - 8 months ago

$ICVX: SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates $ICVX, DSKE, RAIN, CNSL https://www.chartmill.com/stock/quote/ICVX/news?utm_source=prnews-2024-1-4-shareholder-investigation-halper-sadeh-llc-investigates-icvx-dske-rain-cnsl&utm_medium=stocktwits&utm_campaign=pressRelease

User Image risenhoover Posted - 8 months ago

$ICVX ICVX / Icosavax, Inc. downgraded by Guggenheim https://fintel.io/sfo/us/icvx?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=upgrade

User Image StockInvest_us Posted - 12/29/23

Signal alert: $ICVX - Overvalued https://stockinvest.us/l/sLKvA6KtVm

User Image cctranscripts Posted - 12/27/23

Solicitation, recommendation statements https://www.conferencecalltranscripts.org/summary/?id=12823034 $ICVX

User Image risenhoover Posted - 12/27/23

$ICVX / Icosavax files form SC 14D9 https://fintel.io/doc/sec-icosavax-inc-1786255-sc-14d9-2023-december-27-19718-9609?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing

User Image cctranscripts Posted - 12/27/23

Tender offer statement by Third Party https://www.conferencecalltranscripts.org/summary/?id=12822930 $ICVX

User Image tickeron Posted - 12/25/23

$ICVX 4 Insiders at Icosavax sold 187,206 shares last week for $2.9M https://srnk.us/go/4950557

User Image InsiderPeek Posted - 12/23/23

$ICVX . Chief Medical Officer Kanesa-Thasan Niranjan sold 11.9k shares for $183.7k (ownership down 5.04%) . Chief Business Officer Cearley Cassia sold 7.9k shares for $122.6k (ownership down 5.72%) . CFO Russo Thomas Joseph sold 15.2k shares for $234.7k (ownership down 28.53%) insiderpeek.com/company/ICVX

Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Simpson Adam K. Chief Executive Offi.. Chief Executive Officer Jan 30 Sell 15.29 15,000 229,350 358,657 02/02/24
Simpson Adam K. Chief Executive Offi.. Chief Executive Officer Jan 30 Option 1.04 15,000 15,600 373,657 02/02/24
Simpson Adam K. Chief Executive Offi.. Chief Executive Officer Jan 22 Option 0.94 98,016 92,135 358,657 01/23/24
Kanesa-thasan Niranjan Chief Medical Office.. Chief Medical Officer Jan 04 Sell 15.7 106,373 1,670,056 223,980 01/05/24
Kanesa-thasan Niranjan Chief Medical Office.. Chief Medical Officer Jan 04 Option 5.7 106,373 606,326 330,353 01/05/24
Simpson Adam K. Chief Executive Offi.. Chief Executive Officer Jan 02 Sell 15.67 15,000 235,050 260,641 01/04/24
Simpson Adam K. Chief Executive Offi.. Chief Executive Officer Jan 02 Option 1.04 15,000 15,600 275,641 01/04/24
Simpson Adam K. Chief Executive Offi.. Chief Executive Officer Dec 20 Sell 15.44 152,205 2,350,045 260,641 12/22/23
Simpson Adam K. Chief Executive Offi.. Chief Executive Officer Dec 20 Option 1.45 165,917 240,580 350,641 12/22/23
Russo Thomas Joseph Chief Financial Offi.. Chief Financial Officer Dec 20 Sell 15.46 15,183 234,729 38,037 12/22/23
Kanesa-thasan Niranjan Chief Medical Office.. Chief Medical Officer Dec 20 Sell 15.4571 11,884 183,692 223,980 12/22/23
Cearley Cassia Chief Business Offic.. Chief Business Officer Dec 20 Sell 15.4571 7,934 122,637 130,694 12/22/23
Cearley Cassia Chief Business Offic.. Chief Business Officer Dec 13 Sell 16.0053 8,759 140,190 131,200 12/15/23
Simpson Adam K. Chief Executive Offi.. Chief Executive Officer Aug 01 Option 0.84 3,000 2,520 246,930 08/01/23
Kanesa-thasan Niranjan Chief Medical Office.. Chief Medical Officer Jul 31 Sell 8.8615 3,323 29,447 235,864 08/01/23
Simpson Adam K. Chief Executive Offi.. Chief Executive Officer Jul 31 Sell 8.8615 11,788 104,459 243,930 08/01/23
Russo Thomas Joseph Chief Financial Offi.. Chief Financial Officer Jul 31 Sell 8.8615 3,066 27,169 45,620 08/01/23
Cearley Cassia Chief Business Offic.. Chief Business Officer Jul 31 Sell 8.8615 1,888 16,731 139,959 08/01/23
Holtzman Douglas Chief Scientific Off.. Chief Scientific Officer Jul 03 Sell 9.16 16,356 149,821 290,054 07/03/23
Holtzman Douglas Chief Scientific Off.. Chief Scientific Officer Jul 03 Option 1.04 16,356 17,010 306,410 07/03/23
Cearley Cassia Chief Business Offic.. Chief Business Officer May 23 Sell 10.00 10,000 100,000 141,847 05/25/23
Holtzman Douglas Chief Scientific Off.. Chief Scientific Officer Apr 03 Sell 6.32 20,443 129,200 290,054 04/05/23
Holtzman Douglas Chief Scientific Off.. Chief Scientific Officer Apr 03 Option 1.04 20,443 21,261 310,497 04/05/23
Cearley Cassia Chief Business Offic.. Chief Business Officer Mar 06 Sell 7.7474 5,000 38,737 151,847 03/08/23
Simpson Adam K. Chief Executive Offi.. Chief Executive Officer Feb 15 Option 1.04 10,677 11,104 255,718 02/16/23
Bekiroglu Elizabeth General Counsel & Co.. General Counsel & Corp. Sec. Feb 13 Sell 10.6926 5,922 63,322 103,007 02/15/23
Simpson Adam K. Chief Executive Offi.. Chief Executive Officer Feb 13 Sell 10.6926 7,506 80,259 245,041 02/15/23
Holtzman Douglas Chief Scientific Off.. Chief Scientific Officer Feb 13 Sell 10.43 4,871 50,805 290,054 02/15/23
Russo Thomas Joseph Chief Financial Offi.. Chief Financial Officer Feb 13 Sell 10.6926 1,902 20,337 48,686 02/15/23
Kanesa-thasan Niranjan Chief Medical Office.. Chief Medical Officer Feb 13 Sell 10.6926 1,794 19,183 239,187 02/15/23
Cearley Cassia Chief Business Offic.. Chief Business Officer Feb 13 Sell 10.6926 1,660 17,750 156,847 02/15/23
Simpson Adam K. Chief Executive Offi.. Chief Executive Officer Jan 25 Option 0.94 13,073 12,289 252,547 01/27/23
Simpson Adam K. Chief Executive Offi.. Chief Executive Officer Dec 21 Sell 8.96 66,764 598,205 225,105 12/23/22
Simpson Adam K. Chief Executive Offi.. Chief Executive Officer Dec 21 Option 0.84 14,369 12,070 239,474 12/23/22
Holtzman Douglas Chief Scientific Off.. Chief Scientific Officer Dec 15 Sell 11.1443 19,648 218,963 2,792 12/16/22
Bekiroglu Elizabeth General Counsel & Co.. General Counsel & Corp. Sec. Sep 08 Sell 4.8731 1,813 8,835 108,929 09/09/22
Simpson Adam K. Chief Executive Offi.. Chief Executive Officer Jul 29 Sell 6.82 11,377 77,591 291,869 08/02/22
Russo Thomas Joseph Chief Financial Offi.. Chief Financial Officer Jul 29 Sell 6.82 2,959 20,180 48,921 08/02/22
Holtzman Douglas Chief Scientific Off.. Chief Scientific Officer Jul 29 Sell 6.82 10,375 70,758 293,258 08/02/22
Richardson Charles E SVP, Technical Opera.. SVP, Technical Operations Jul 29 Sell 6.82 2,218 15,127 165,168 08/02/22
Kanesa-thasan Niranjan Chief Medical Office.. Chief Medical Officer Jul 29 Sell 6.82 3,245 22,131 239,314 08/02/22
Cearley Cassia Chief Business Offic.. Chief Business Officer Jul 29 Sell 6.82 1,812 12,358 131,738 08/02/22
Simpson Adam K. Chief Executive Offi.. Chief Executive Officer Jul 01 Option 0.84 7,185 6,035 303,245 07/06/22
Simpson Adam K. Chief Executive Offi.. Chief Executive Officer Mar 28 Option 0.84 4,789 4,023 220,482 03/30/22
Cearley Cassia Chief Business Offic.. Chief Business Officer Mar 07 Sell 17.47 10,000 174,700 98,413 03/09/22
Richardson Charles E SVP, Technical Opera.. SVP, Technical Operations Feb 14 Option 0.94 72,561 68,207 167,386 02/16/22
Kanesa-thasan Niranjan Chief Medical Office.. Chief Medical Officer Feb 02 Option 0.94 52,752 49,587 221,408 02/04/22
Simpson Adam K. Chief Executive Offi.. Chief Executive Officer Jan 26 Option 0.94 90,693 85,251 215,693 01/28/22